The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Needham: Maintaining a "buy" rating on Artiva Biotherapeutics ( Artiva Biotherapeutics, Inc.(ARTV.US) ), while raising the price target from $18 to $41.

HC Wainwright & Co.: Maintaining a "buy" rating on SAB Biotherapeutics ( SAB Biotherapeutics Inc Ordinary Shares(SABS.US) , raising the price target from $7 to $10.

Citizens: Maintaining MBX Biosciences' ( MBX Biosciences, Inc.(MBX.US) ) rating at "Outperform Market," while raising the price target from $76 to $86.

Jefferies: Initial rating for Kailera Therapeutics ( Kailera Therapeutics, Inc.(KLRA.US) ) at "Buy", with a target price of $48.

Wells Fargo: Maintaining an "overweight" rating on Metagenomi Therapeutics ( Metagenomi Therapeutics, Inc.(MGX.US) ), while lowering its price target from $12 to $9.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
Artiva Biotherapeutics, Inc.(ARTV.US)	to lift	$41.0	$10.63	285.7%	Needham
SAB Biotherapeutics Inc Ordinary Shares(SABS.US)	to lift	$10.0	$3.62	176.24%	HC Wainwright & Co.
MBX Biosciences, Inc.(MBX.US)	to lift	$86.0	$36.98	132.56%	Citizens
MBX Biosciences, Inc.(MBX.US)	to lift	$70.0	$36.98	89.29%	Barclays
CI&T, Inc. Class A(CINT.US)	to lift	$7.2	$3.82	88.48%	UBS
Kailera Therapeutics, Inc.(KLRA.US)	Initial classification	$48.0	$22.3	115.25%	Jefferies
Metagenomi Therapeutics, Inc.(MGX.US)	cut	$9.0	$1.35	566.67%	Wells Fargo
LENZ Therapeutics, Inc.(LENZ.US)	cut	$38.0	$7.91	380.4%	HC Wainwright & Co.
Intellia Therapeutics, Inc.(NTLA.US)	cut	$49.0	$13.99	250.25%	Canaccord Genuity
Cartesian Therapeutics, Inc.(RNAC.US)	cut	$25.0	$8.7	187.36%	HC Wainwright & Co.

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Mizuho: Maintaining Advanced Micro Devices, Inc.(AMD.US) rating at "Outperform Market", while raising the price target from $415 to $515.

Citigroup: Maintaining a "buy" rating on Broadcom Broadcom Limited(AVGO.US) ) stock, while raising its price target from $475 to $500.

Mizuho: Maintaining a "neutral" rating on Coinbase Global Coinbase(COIN.US) ) stock, while raising the price target from $170 to $200.

Goldman Sachs: Maintaining a "Sell" rating on Datadog ( Datadog(DDOG.US) ), while raising the price target from $121 to $139.

Mizuho: Maintaining Dell Dell Technologies, Inc. Class C(DELL.US) rating at "Outperforming the Market," while raising the price target from $260 to $300.

Needham: Maintaining a "buy" rating on Hims & Hers Health ( Hims & Hers Health(HIMS.US) ), while raising the price target from $30 to $35.

Citigroup: Maintaining a "neutral" rating on HIMS ( Hims & Hers Health(HIMS.US) ) stock, while raising the price target from $24 to $28.

Wells Fargo: Maintaining an "overweight" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising its price target from $265 to $315.

Oppenheimer: Maintaining Oracle's Oracle Corporation(ORCL.US) rating at "Outperforming the Market," while raising the price target from $210 to $235.

Mizuho: Maintaining a "neutral" rating on Super Micro Computer ( Super Micro Computer, Inc.(SMCI.US) ), while raising the price target from $30 to $36.

First Coverage

Goldman Sachs: Initial rating for AEVEX ( AEVEX Corp. Class A(AVEX.US) ) stock at "buy", with a target price of $34.

Evercore ISI Group: Initial rating for Benitec Biopharma ( Benitec Biopharma Inc(BNTC.US) ) at "Outperform," with a target price of $25.

Craig-Hallum: Initial rating for Boost Run ( Boost Run Inc. Class A(BRUN.US) ) stock at "Buy", with a target price of $30.

Wells Fargo: Initial rating for Southwest Gas Holdings ( Southwest Gas Holdings, Inc.(SWX.US) ) at "overweight", with a target price of $105.

reduction

Citigroup: Maintaining a "neutral" rating on Salesforce ( Salesforce.com, inc.(CRM.US) ) stock, while lowering its price target from $200 to $188.

JP Morgan: Maintaining an "overweight" rating on Hims & Hers Health ( Hims & Hers Health(HIMS.US) ), while lowering the price target from $35 to $33.

Truist Securities: Maintaining a "buy" rating on Mastercard Mastercard(MA.US) ) stock, while lowering the price target from $590 to $561.

Truist Securities: Maintains its "Hold" rating on SoFi SoFi(SOFI.US) , while lowering its price target from $20 to $17.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.